483 Roundup: Seven Companies Cited for Quality Transgressions

Drug GMP Report
A A
The FDA hit seven drugmakers for quality-related violations, including issues with shared equipment and complaint evaluation.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $200.00